EMILY PARTIDA: Open Payments
NPI 1114707114 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 12 payments from 7 companies in 2025. Trend: 2023 $204 · 2024 $3,273 · 2025 $625
Food & beverage: $526Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $224 |
| Sumitomo Pharma America, Inc. | 3 | $140 |
| Boston Scientific Corporation | 1 | $134 |
| Ferring Pharmaceuticals Inc. | 3 | $69 |
| Janssen Biotech, Inc. | 1 | $28 |
| Medtronic, Inc. | 1 | $16 |
| UROGEN PHARMA, INC. | 1 | $14 |
Products named: GEMTESA, Axonics, Xtandi, ADSTILADRIN, ERLEADA, INTERSTIM, JELMYTO.
Industry payments across TX — which companies pay providers there.
